BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8577033)

  • 1. [Metabolic pathway of the degradation of macromolecules by lysosomal enzymes].
    Arai K; Ohkuma S
    Nihon Rinsho; 1995 Dec; 53(12):2904-10. PubMed ID: 8577033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal metabolism of glycoproteins.
    Winchester B
    Glycobiology; 2005 Jun; 15(6):1R-15R. PubMed ID: 15647514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disorders of glycoprotein degradation].
    Yoshida K; Yanagisawa N
    Nihon Rinsho; 1995 Dec; 53(12):2973-81. PubMed ID: 8577045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Storage problems in lysosomal diseases.
    Heard JM; Bruyère J; Roy E; Bigou S; Ausseil J; Vitry S
    Biochem Soc Trans; 2010 Dec; 38(6):1442-7. PubMed ID: 21118104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfotransferases and sulfated oligosaccharides.
    Honke K; Taniguchi N
    Med Res Rev; 2002 Nov; 22(6):637-54. PubMed ID: 12369092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
    Sandhoff K; Kolter T
    Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glycolipids of the cell surface--biochemistry of their decomposition].
    Sandhoff K; Kolter T
    Naturwissenschaften; 1995 Sep; 82(9):403-13. PubMed ID: 7477413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some inherited lysosomal enzyme defects with special reference to the liver and prospects for their control.
    Watts RW
    Z Gastroenterol Verh; 1979; 16():137-43. PubMed ID: 95365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lysosomal storage diseases--an overview].
    Kloska A; Tylki-Szymańska A; Wegrzyn G
    Postepy Biochem; 2011; 57(2):128-32. PubMed ID: 21913413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathobiochemical aspects of lysosomal enzymes with special reference to lysosomal storage diseases (author's transl)].
    Kresse H
    Wien Klin Wochenschr; 1978 May; 90(10):325-32. PubMed ID: 418578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The glycosphingolipidoses-from disease to basic principles of metabolism.
    Schuette CG; Doering T; Kolter T; Sandhoff K
    Biol Chem; 1999; 380(7-8):759-66. PubMed ID: 10494825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in membrane trafficking and pathophysiological implications in lysosomal storage disorders.
    Kuech EM; Brogden G; Naim HY
    Biochimie; 2016 Nov; 130():152-162. PubMed ID: 27664461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular trafficking of lysosomal membrane proteins.
    Hunziker W; Geuze HJ
    Bioessays; 1996 May; 18(5):379-89. PubMed ID: 8639161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infantile sialic acid storage disease: biochemical studies.
    Berra B; Gornati R; Rapelli S; Gatti R; Mancini GM; Ciana G; Bembi B
    Am J Med Genet; 1995 Jul; 58(1):24-31. PubMed ID: 7573152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Three sources and three component parts" of free oligosaccharides.
    Pismenetskaya IU; Butters TD
    Ukr Biochem J; 2014; 86(6):5-17. PubMed ID: 25816601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lysosome: from waste bag to potential therapeutic target.
    Appelqvist H; Wäster P; Kågedal K; Öllinger K
    J Mol Cell Biol; 2013 Aug; 5(4):214-26. PubMed ID: 23918283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of glycoconjugates in human gastric mucosa a review.
    Zwierz K; Gindzienski A; Ostrowska L; Stankiewicz-Choroszucha B
    Acta Med Hung; 1989; 46(4):275-88. PubMed ID: 2699919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lysosomes and lysosomal storage diseases].
    Germain DP
    J Soc Biol; 2002; 196(2):127-34. PubMed ID: 12360741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal storage diseases: cellular pathology, clinical and genetic heterogeneity, therapy.
    Reuser AJ; Kroos MA; Visser WJ; Willemsen R
    Ann Biol Clin (Paris); 1994; 52(10):721-8. PubMed ID: 7747880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriating microbial catabolism: a proposal to treat and prevent neurodegeneration.
    de Grey AD
    Neurobiol Aging; 2006 Apr; 27(4):589-95. PubMed ID: 16207503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.